Evidence map›Paper›PMID 29114105›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2018

Neuregulin 3 Signaling Mediates Nicotine-Dependent Synaptic Plasticity in the Orbitofrontal Cortex and Cognition.

Luyi Zhou, Miranda L Fisher, Robert D Cole, Thomas J Gould, Vinay Parikh, Pavel I Ortinski, Jill R Turner

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Transcriptomic identification and developmental mapping ofTurkish journal of biology = Turk biyoloji dergisi · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Translational Research in Nicotine Addiction.Cold Spring Harbor perspectives in medicine · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Neuregulins in Neurodegenerative Diseases.Frontiers in aging neuroscience · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Luyi ZhouDepartment of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, USA.
Miranda L FisherDepartment of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, USA.ORCID 0000-0003-4394-9796
Robert D ColeDepartment of Psychology, Temple University, Philadelphia, PA, USA.
Thomas J GouldDepartment of Biobehavioral Health, Pennsylvania State University, University Park, PA, USA.
Vinay ParikhDepartment of Psychology, Temple University, Philadelphia, PA, USA.
Pavel I OrtinskiDepartment of Pharmacology, Physiology, and Neuroscience, University of South Carolina School of Medicine, Columbia, SC, USA.
Jill R TurnerDepartment of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, USA.ORCID 0000-0002-7258-1639
University of South Carolina · USTemple University · USPennsylvania State University · US

Funding

Dynamic Signaling of NRG3-ErbB4 in the Hippocampus Mediates Nicotine Withdrawal PhenotypesR01DA044311 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI TURNER, JILL R. · 2018 to 2022
$1.9M
Control of Cocaine Seeking by D1-dependent Modulation of NMDA SignalingK01DA031747 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI ORTINSKI, PAVEL IVANOVICH · 2012 to 2016
$696k
Cognitive control and corticostriatal BDNF signaling during nicotine withdrawalR03DA037421 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI PARIKH, VINAY · 2015 to 2016
$155k
NIDA NIH HHS K01 DA031747NIDA NIH HHS R01 DA044311NIDA NIH HHS R03 DA037421
6 · The paper itself

Abstract

Neuregulin 3 (NRG3) and ErbB4 have been linked to nicotine addiction; however, the neuronal mechanisms and behavioral consequences of NRG3-ErbB4 sensitivity to nicotine remain elusive. Recent literature suggests that relapse to smoking is due to a lack of impulsive control, which is thought to be due to altered functioning within the orbitofrontal cortex (OFC). Therefore, we examined circuitry changes within this structure following nicotine application. We report that nicotine controls synaptic plasticity in the OFC through NRG3/ErbB4-dependent regulation of GABAergic inhibition. We observed that both nicotine and NRG3 facilitated the conversion of long-term potentiation into long-term depression at cortical layer 3/5 synapses. Induction of long-term depression by nicotine relied on nicotinic receptor activation and key regulators of NRG3 signaling: (1) release of intracellular calcium, (2) activation of the BACE1 beta-secretase, and (3) ErbB4 receptor activation. Nicotine-induced synaptic plasticity was also associated with accumulation of intracellular GABA and was completely blocked by GABA

Indexed as

AnimalsCognitiongamma-Aminobutyric AcidIntracellular Signaling Peptides and ProteinsMaleMice, 129 StrainMice, TransgenicNeural InhibitionNeuregulinsNeuronal PlasticityNeuronsNicotineNicotinic AgonistsPrefrontal CortexReceptor, ErbB-4Signal TransductionErbb4 protein, mousegamma-Aminobutyric AcidIntracellular Signaling Peptides and ProteinsNeuregulinsNicotineNicotinic AgonistsNrg3 protein, mouseReceptor, ErbB-4

Identifiers

PMID29114105
PMCPMC5916355
OpenAlexW2767338743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.